James Tankel, Rawan Sakalla, Neyla Boukhili, Mehrnoush Dehghani, Jonathan Spicer, Sara Najmeh, Jonathan Cools-Lartigue, Jamil Asselah, Sara Soldera, Thierry Alcindor, Joanne Alfieri, Marc David, Carmen Mueller, Lorenzo Ferri
BACKGROUND: Survival among esophageal cancer patients with stage IV non-regional lymphadenopathy treated with neoadjuvant therapy and surgical resection is not well described. This study aimed to compare the survival outcomes of patients with non-regional lymphadenopathy with a propensity matched cohort of patients with loco-regional disease. METHODS: A retrospective cohort analysis of a prospectively maintained database from a regional upper gastrointestinal cancer network in Quebec, Canada was performed...
April 2, 2024: Journal of Gastrointestinal Surgery